---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-088184"
form_type: "8-K/A"
ticker: "FENC"
cik: "0001211583"
company_name: "FENNEC PHARMACEUTICALS INC."
filed_at: "2023-08-07T23:59:59+00:00"
generated_at: "2026-06-12T03:47:41.546877+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Fennec Q2 revenue $3.3M (+98% QoQ); appoints Adrian Haigh as COO

## Summary
- Net product revenue $3.3M in Q2 2023, up 98% from $1.7M in Q1 2023.
- Net loss $5.4M ($0.21/share) vs $5.1M ($0.19/share) year ago.
- Adrian Haigh appointed COO, steps down from board; base salary €400K, 200K options.
- Cash $15.0M at June 30, 2023; sufficient for at least 12 months.

## SEC filing metadata
- accession: 0001104659-23-088184
- form_type: 8-K/A
- ticker: FENC
- cik: 0001211583
- company_name: FENNEC PHARMACEUTICALS INC.
- filed_at: 2023-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1211583/000110465923088184/0001104659-23-088184-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1211583/000110465923088184/tm2323025-1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-088184
- JSON: https://secwatch.observer/filing/0001104659-23-088184.json
- Plain text: https://secwatch.observer/filing/0001104659-23-088184.txt

## Key facts
- Executive change
  Adrian Haigh was appointed as Chief Operating Officer at FENNEC PHARMACEUTICALS INC..
  - Action: appointed
  - Role: Chief Operating Officer
  source text: Mr. Haigh had accepted the appointment as Chief Operating Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1211583/000110465923088184/0001104659-23-088184-index.htm
- Executive change
  Adrian Haigh departed as Director at FENNEC PHARMACEUTICALS INC..
  - Action: stepped down
  - Role: Director
  source text: Adrian Haigh had stepped down from the the position of Director of Fennec Pharmaceuticals Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1211583/000110465923088184/0001104659-23-088184-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.